首页> 外文期刊>Revista Brasileira de Anestesiologia >Hyperalgesic effect of subarachnoid administration of phentolamine in mice
【24h】

Hyperalgesic effect of subarachnoid administration of phentolamine in mice

机译:蛛网膜下腔注射酚妥拉明对小鼠的镇痛作用

获取原文
           

摘要

CALLEGARI, Desiré Carlos et al. Hyperalgesic effect of subarachnoid administration of phentolamine in mice. Rev. Bras. Anestesiol. [online]. 2015, vol.65, n.2, pp.111-116. ISSN 0034-7094.? http://dx.doi.org/10.1016/j.bjane.2013.09.013. BACKGROUND AND OBJECTIVES: Painful phenomenon is one of the most important and complex experiences. Phentolamine is a non-selective alpha-adrenergic antagonist. The objective of this study was to compare the effect of increasing doses of phentolamine into subarachnoid space in rats in the modulation of painful phenomenon. METHODS: 84 male Wistar rats were divided into formalin and plantar incision groups, subdivided into six subgroups (n = 7). Control group received only saline (10 μL); active subgroups received phentolamine 10 μmg (GF10), 20 mg (GF20), 30 mg (GF30), 40 mg (GF40), and 50 g (GF50). In formalin group, pain was induced by injection of 50 μL of 2% formalin in dorsal region of right posterior paw. In plantar incision group, pain was induced by plantar incision and evaluated using von Frey filaments. Induction and maintenance of anesthesia were performed with 3% halothane for catheter placement into subarachnoid space and plantar incision. Statistical analysis was performed using the JMP program from SAS with 5% significance level. RESULTS: Phentolamine at doses of 20 and 30 g increased the algesic response in the intermediate phase of the formalin test. In plantar incision test, it had hyperalgic effect on first, third, fifth, and seventh days at a dose of 10 g and on first, third, and fifth days at a dose of 20 g and on fifth day at a dose of 30 g. CONCLUSION: Subarachnoid administration of phentolamine showed hyperalgesic effect, possibly due to the involvement of different subclasses of alpha-adrenergic receptors in modulating pain pathways.
机译:卡莱加里(CALLEGARI),德西·卡洛斯(DesiréCarlos)等。蛛网膜下腔注射酚妥拉明对小鼠的镇痛作用。胸罩牧师茴香醚。 [线上]。 2015年,第65卷,第2期,第111-116页。 ISSN 0034-7094。? http://dx.doi.org/10.1016/j.bjane.2013.09.013。背景与目的:痛苦现象是最重要,最复杂的经历之一。酚妥拉明是一种非选择性的α-肾上腺素能拮抗剂。这项研究的目的是比较增加剂量的酚妥拉明进入大鼠蛛网膜下腔对疼痛现象的调节作用。方法:将84只雄性Wistar大鼠分为福尔马林和足底切口组,再分为六个亚组(n = 7)。对照组仅接受生理盐水(10μL);活跃的亚组分别接受苯妥拉明10μmg(GF10),20 mg(GF20),30 mg(GF30),40 mg(GF40)和50 g(GF50)。在福尔马林组,右后足背侧注射50μL2%福尔马林引起疼痛。在足底切口组中,由足底切口引起疼痛并使用von Frey细丝进行评估。用3%的氟烷进行诱导和维持麻醉,以将导管置入蛛网膜下腔和足底切口。使用SAS的JMP程序以5%的显着性水平进行统计分析。结果:在20和30 g剂量的酚妥拉明在福尔马林测试的中期增加了痛觉过敏反应。在足底切口试验中,它在剂量为10 g的第一,第三,第五和第七天,剂量为20 g的第一,第三和第五天,以及第五天的剂量为30 g时有过敏反应。结论:蛛网膜下腔注射酚妥拉明具有镇痛作用,这可能是由于α-肾上腺素受体的不同亚类参与了疼痛通路的调节。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号